Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 2.14 -39.89%

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Interest Expense 2011-2024 | EGRX

Annual Interest Expense Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
4.04 M 1.64 M 2.58 M 2.69 M 2.74 M 1.14 M 8 K 11 K 8 K 309 K 91 K -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
4.04 M 8 K 1.39 M

Quarterly Interest Expense Eagle Pharmaceuticals

2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
1.45 M 1.52 M - 1.15 M 552 K 366 K - 396 K 422 K 422 K - 489 K 786 K 889 K - 628 K 665 K 686 K - 743 K 701 K 675 K - 527 K 40 K 27 K - 3 K 3 K - - 5 K 3 K 1 K 1 K 2 K 5 K 1 K - 309 K 16 K 145 K - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
1.52 M 1 K 426 K